Blog
RSS FeedPosted by Michael Wonder on 31 May 2017
New action plan to support SMEs as drivers of pharmaceutical innovation
31 May 2017 - 16 actions identified for implementation in 2017-2020. ...
Posted by Michael Wonder on 27 Feb 2017
GSK ‘real world’ study offers new model for drug trials
27 February 2017 - Pharma groups look to evidence in normal medical settings to prove value for money. ...
Posted by Michael Wonder on 02 Feb 2017
Outcomes of early health technology assessment dialogues in medicinal product development
2 February 2017 - The development of medicinal products has been shifting towards a value-driven model. ...
Posted by Michael Wonder on 18 Dec 2016
Tailored scientific advice to support step-by-step development of new biosimilars
16 December 2016 - Pilot project to commence in February 2017. ...
Posted by Michael Wonder on 13 Dec 2016
EMA hosts workshop on adaptive pathways
13 December 2016 - Broad range of stakeholder questions addressed. ...
Posted by Michael Wonder on 15 Nov 2016
Pharmaceutical companies' strategies for reaching the poor are maturing but expansion is gradual
14 November 2016 - Pharmaceutical companies are getting more sophisticated in the way they get products to poor people and are ...
Posted by Michael Wonder on 14 Nov 2016
Modelling and simulation in the development of medicines
14 November 2016 - Watch live broadcast of expert discussion at EMA. ...
Posted by Michael Wonder on 14 Nov 2016
How to facilitate development of cancer treatment based on genetically modified T-cells
8 November 2016 - Watch live broadcast of expert discussion at EMA. ...
Posted by Michael Wonder on 13 Nov 2016
How big data can be used for the development and regulation of medicines
8 November 2016 - EMA workshop broadcast live on 14-15 November. ...
Posted by Michael Wonder on 20 Oct 2016
Opening up clinical data on new medicines
20 October 2016 - EMA provides public access to clinical reports. ...
Posted by Michael Wonder on 26 Sep 2016
EU-US collaboration to boost medicine development for rare diseases
26 September 2016 - The EMA and the U.S. FDA have set up a new ‘cluster’ on rare diseases to share ...
Posted by Michael Wonder on 19 Aug 2016
“Adaptive pathways” to drug authorisation: adapting to industry?
16 August 2016 - The evidence for benefits of adaptive pathways to patients and public health is lacking or contradictory, ...
Posted by Michael Wonder on 16 Aug 2016
Addressing challenges of innovative cancer immunotherapy medicines
16 August 2016 - EMA workshop to discuss treatments based on genetically modified T-cells. ...
Posted by Michael Wonder on 04 Aug 2016
Adaptive pathways: key learnings and next steps
3 August 2016 - EMA publishes report on pilot project and will organise workshop in December to further explore concept ...
Posted by Michael Wonder on 03 Aug 2016
New layout for EMA scientific guidelines
2 August 2016 - Improved presentation to help website users. ...